thiazoles has been researched along with Epithelial Ovarian Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ledermann, JA | 1 |
| Aghajanian, C; Barry, WT; Birrer, M; Buss, MK; Cadoo, KA; Cantley, LC; Coleman, RL; Curtis, J; D'Andrea, AD; Eismann, J; Farooq, S; Kaufmann, SH; Kirschmeier, P; Kochupurakkal, B; Konstantinopoulos, PA; Liu, J; Luo, W; Matulonis, UA; Mayer, EL; Mills, GB; O'Cearbhaill, RE; Palakurthi, S; Shapiro, GI; Swisher, EM; Westin, SN; Whalen, C; Winer, E; Wulf, GM | 1 |
| Bocchicchio, S; Irusta, G; Tesone, M | 1 |
| Chen, X; Dai, H; Qian, Z; Wang, Y; Xu, X; Zhao, Y | 1 |
| Bae-Jump, VL; Chan, LL; Jones, HM; Ma, X; Song, F; Wang, J; Zhang, W; Zhou, C | 1 |
| Cho, H; Chung, JY; Kang, ES; Kim, JH; Lee, EJ; Shin, HY; Yang, W | 1 |
| Alpaugh, RK; Brady, WE; Fiorica, JV; Godwin, AK; Hu, W; Lankes, HA; Mannel, RS; Pathak, HB; Schilder, RJ; Shahin, MS; Sood, AK; Zhou, XC | 1 |
2 trial(s) available for thiazoles and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Genome, Human; Humans; Maximum Tolerated Dose; Middle Aged; Mutation; Ovarian Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Thiazoles; Treatment Outcome | 2019 |
Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Dasatinib; Disease-Free Survival; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Mas; Pyrimidines; Thiazoles | 2012 |
5 other study(ies) available for thiazoles and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Extending the scope of PARP inhibitors in ovarian cancer.
Topics: Carcinoma, Ovarian Epithelial; Female; Humans; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Thiazoles | 2019 |
Convergence of Wnt and Notch signaling controls ovarian cancer cell survival.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Ovarian Epithelial; Cell Movement; Cell Proliferation; Cell Survival; Diamines; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Pyrimidinones; Receptors, Notch; Signal Transduction; Thiazoles; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2019 |
In vitro chemosensitivity assay of ascites in epithelial ovarian cancer.
Topics: Antineoplastic Agents; Ascites; Carboplatin; Carcinoma, Ovarian Epithelial; Coloring Agents; Deoxycytidine; Disease Progression; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2013 |
Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Carcinoma, Ovarian Epithelial; Cell Cycle Checkpoints; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Protein Multimerization; Proto-Oncogene Proteins c-myc; Thiazoles; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2014 |
Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer.
Topics: Animals; Apoptosis; Carcinoma, Ovarian Epithelial; CDC2 Protein Kinase; Cell Line, Tumor; Cisplatin; Cytoplasm; Female; Gene Expression Profiling; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphorylation; Prognosis; Proportional Hazards Models; Quinolines; ROC Curve; Survival Rate; Thiazoles; Time Factors; Tissue Array Analysis; Treatment Outcome | 2016 |